首页> 外国专利> Orally Administrable Pharmaceutical Preparation Having Therapeutic Effect on Gastrointestinal Disorders Comprising Coated Ranitidine Bismuth Subcitrate and Sucralfate

Orally Administrable Pharmaceutical Preparation Having Therapeutic Effect on Gastrointestinal Disorders Comprising Coated Ranitidine Bismuth Subcitrate and Sucralfate

机译:口服给药的对胃肠道疾病有治疗作用的药物制剂,包括雷尼替丁亚柠檬酸铋和硫糖铝酸涂层

摘要

PURPOSE: Provided is an orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders which comprises as active ingredients ranitidine, bismuth subcitrate and sucralfate, wherein the ranitidine is coated with a coating agent to have a film dissolution time ranging from 20 to 90 minutes. CONSTITUTION: The orally administrable pharmaceutical preparation has therapeutic effect on gastrointestinal disorders which comprises as active ingredients ranitidine, bismuth subcitrate and sucralfate, wherein the ranitidine is coated with a coating agent to have a film dissolution time ranging from 20 to 90 minutes, preferably 30 to 70 minutes; the coating agent is an enteric coating agent selected from the group consisting of hydroxypropyl methylcellulose, methylcellulose and Eudragit; and the preparation is pharmaceutically manufactured into granules, capsules, tablets or double-layer tablets comprising coated tablet cores.
机译:用途:提供对胃肠道疾病具有治疗作用的口服药物制剂,其包含雷尼替丁,次柠檬酸铋和硫糖铝作为活性成分,其中雷尼替丁用包衣剂包衣以具有20至90分钟的膜溶解时间。组成:口服药物制剂对胃肠道疾病具有治疗作用,其包含雷尼替丁,次柠檬酸铋和硫糖铝作为活性成分,其中雷尼替丁用包衣剂包衣,其薄膜溶解时间为20至90分钟,优选30至90分钟。 70分钟;包衣剂是选自羟丙基甲基纤维素,甲基纤维素和Eudragit的肠溶包衣剂。将该制剂药学上制成包含包衣片芯的颗粒剂,胶囊剂,片剂或双层片剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号